The Marketplace Reader
'Exercise in a pill' still needs a workout
News that scientists have developed a drug that mimics the benefits of exercise — in mice, anyway — quickly rose to the top of numerous websites today.
“We have exercise in a pill,” Ron Evans (pictured), an author of a study on the drug called AICAR said in an Associated Press story. “With no exercise, you can take a drug and chemically mimic it.” Evans, of the Salk Institute for Biological Studies and the Howard Hughes Medical Institute, is one of a team of scientists who first reported the findings in an article posted on the website of the journal Cell.
But, as the AP report states, the drug’s impact on humans is still unknown:
Sedentary mice that took the drug for four weeks burned more calories and had less fat than untreated mice. And when tested on a treadmill, they could run about 44 percent farther and 23 percent longer than untreated mice.
Just how well those results might translate to people is an open question. But someday, researchers say, such a drug might help treat obesity, diabetes and people with medical conditions that keep them from exercising.
Evans said his team has already developed detection tests for use by the World Anti-Doping Agency to head off any athletes who may be looking for an edge.
A story posted on the Wired website included some skepticism from Darrell Neufer, a professor of sports medicine specializing in cellular energy systems at East Carolina University. “It’s going to be nearly impossible to create a pill that will mimic all the benefits that exercise has,” Neufer said.
Neufer cited a 2000 paper by BYU and Washington University scientists that, he said, showed the drug the Salk Institute scientists used “does not fully mimic the adaptive response to exercise.”
- July 31, 2008 — Richard Core
Latest Posts
- Hollywood to Seattle: We said no copies!
- South fumes over continued gas shortage
- Revenge, rather than stopping the bleeding
- Maybe $10 million will help you lighten up
- Delta, Northwest shareholders voting today on joining together
- Start your engines -- with a cell phone
- Goldman Sachs gets big boost from Buffett
- More victims of the Wall Street crisis
- An Emmy's theme
- What's your opinion on the bailout?
- Going soft on us
- Thanks for the memories
- The sweet deal
- Botox might help migraines
- The new Beatles Monopoly game -- Yeah, yeah, yeah!
- Heads up: Air New Zealand is looking for a few bald men
- United stock plunges on really big oops
- Bad buzz on Seinfeld and Gates ad
- Will it be easy being green -- and red?
- More hot wheels
- Hot wheels
- Google unveils new browser
- California lawmakers push for carbon-reduction planning
- GM to salaried workers: Why not retire now?
- Scientists develop cells that could be disease fighters
- Want to invest in rock 'n' roll?
- Dell to offer low-cost computers to emerging markets
- Profits in the airline industry!
- Fewer textbooks to carry with Kindle?
- Colleges dropping food trays
- Tropicana down one Indiana riverboat
- Wii have your technology
- Bicycle roundup
- Target adjusts its aim at market
- Treo has a new deal-o
- Tire rolling resistance standards and your fuel efficiency
- Vioxx clinical study influenced by marketing
- Wine expert: boxed wine better for the environment
- Open-source textbooks
- Rupert Murdoch is now frenemies with Facebook
- Technology is the new retail therapy
- I deflate you kindly and anonymously
- Ex-Apple lawyer settles backdating case
- Spain eliminates wealth tax
- Heat pump business is hot, naturally
- iPhone coming to Best Buy
- Money can't buy you love, but . . .
- High-speed Net service hits slowdown
- Hydrogen vehicles go cross-country
- $100 billion to Iraq War contractors
- Scientists: Turning invisible might be possible
- 'Natural' plastic on the horizon?
- Rolling Stone just wants to fit in
- Despite Internet, Yellow Pages multiply
- YouTube's advertising picture still fuzzy
- UBS joins the buy-back brigade
- Putting the brakes on discs?
- Doing something about the weather
- Your start-up's future earnings report, today
- Olympic-size marketing blunders
- Athletic budgets face tough travel costs
- Preparing for the downside of oil
- GM gives battered biofuels a push
- YouTube's going for broadcast gold
- Cablevision wins appeals court ruling on DVRs
- Venture capital growing in green space
- They must have meant 'Fee' Credit Report
- Yahoo annual meeting a quiet affair
- Prius on the high road
- 'Exercise in a pill' still needs a workout
- TSA pockets over $1 million in change
- Watchful eye sponsored by . . . the people of Flint
- All a-Twitter over L.A. quake
- Quake update
- Shake-up at Marketplace -- and all L.A.
- JetBlue CEO latest to suffer with industry
- Slow down, your auto-insurer is watching
- Brits' economic indicator: Fewer pub visits
- What search is 'cooler' than Google?
- Random act of greenness or a job well done?
- Hold on, that may be cancer calling
- Plugging electric cars
- Moscow may be difficult for U.S. expats
- Google does Wikipedia one better -- $
- Hershey's not melting away yet
- Bad days for newspapers, democracy
- Global warming? Just pass the lime
- Adapting to a bleak oil crunch scenario
- Lots of barking over Verizon ad
- Los Angeles keeps it trim
- Another reason not to drive
- Is mystery meat on the menu?
- Reverting to 'booze culture'
- "Borrowers Betrayed"
- At least a temporary drop in oil pressure
- Simon says, 'No more'
- Computers 1, Humans 0
- Espresso-over-ice request heats up online
- Now boarding: passengers holding ads
- Social networking, baby style
sponsor





